These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Vianello A; Guarnieri G; Braccioni F; Lococo S; Molena B; Cecchetto A; Giraudo C; Bertagna De Marchi L; Caminati M; Senna G Clin Chem Lab Med; 2022 Feb; 60(3):307-316. PubMed ID: 34783228 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets. O'Reilly S QJM; 2023 Oct; 116(9):750-754. PubMed ID: 37191984 [TBL] [Abstract][Full Text] [Related]
24. COVID-19 induces more pronounced extracellular matrix deposition than other causes of ARDS. de Souza Xavier Costa N; Ribeiro Júnior G; do Nascimento ECT; de Brito JM; Antonangelo L; Faria CS; Monteiro JS; Setubal JC; Pinho JRR; Pereira RV; Seelaender M; de Castro GS; Lima JDCC; de Almeida Monteiro RA; Duarte-Neto AN; Saldiva PHN; Ferraz da Silva LF; Dolhnikoff M; Mauad T Respir Res; 2023 Nov; 24(1):281. PubMed ID: 37964271 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial. Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163 [TBL] [Abstract][Full Text] [Related]
26. Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators. O'Hare M; Amarnani D; Whitmore HAB; An M; Marino C; Ramos L; Delgado-Tirado S; Hu X; Chmielewska N; Chandrahas A; Fitzek A; Heinrich F; Steurer S; Ondruschka B; Glatzel M; Krasemann S; Sepulveda-Falla D; Lagares D; Pedron J; Bushweller JH; Liu P; Arboleda-Velasquez JF; Kim LA Am J Pathol; 2021 Jul; 191(7):1193-1208. PubMed ID: 33894177 [TBL] [Abstract][Full Text] [Related]
27. Toll-like receptors in the pathogenesis of pulmonary fibrosis. Karampitsakos T; Woolard T; Bouros D; Tzouvelekis A Eur J Pharmacol; 2017 Aug; 808():35-43. PubMed ID: 27364757 [TBL] [Abstract][Full Text] [Related]
28. Sequelae of COVID-19 pneumonia: Is it correct to label everything as post-COVID lung fibrosis? Garg M; Maralakunte M; Dhooria S J Postgrad Med; 2021; 67(4):224-227. PubMed ID: 34845890 [TBL] [Abstract][Full Text] [Related]
29. Interstitial Pulmonary Fibrosis and Extensive Dendriform Ossification with Persistent Viral Load: A Rare Presentation of Post-COVID-19 Condition in Need of Lung Transplantation. Haslbauer JD; Bratic-Hench I; Cima K; Luger AK; Schmitz K; Augustin F; Krapf C; Hoefer D; Tancevski I; Tzankov A; Löffler-Ragg J Pathobiology; 2023; 90(2):138-146. PubMed ID: 35835004 [TBL] [Abstract][Full Text] [Related]
30. CTHRC1: An Emerging Hallmark of Pathogenic Fibroblasts in Lung Fibrosis. Mukhatayev Z; Adilbayeva A; Kunz J Cells; 2024 May; 13(11):. PubMed ID: 38891078 [TBL] [Abstract][Full Text] [Related]
31. Influence of age on wound healing and fibrosis. Kapetanaki MG; Mora AL; Rojas M J Pathol; 2013 Jan; 229(2):310-22. PubMed ID: 23124998 [TBL] [Abstract][Full Text] [Related]
32. The role of extracellular matrix quality in pulmonary fibrosis. Kristensen JH; Karsdal MA; Genovese F; Johnson S; Svensson B; Jacobsen S; Hägglund P; Leeming DJ Respiration; 2014; 88(6):487-99. PubMed ID: 25359084 [TBL] [Abstract][Full Text] [Related]
33. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application. Zhao Y; Yan Z; Liu Y; Zhang Y; Shi J; Li J; Ji F Stem Cell Res Ther; 2021 Aug; 12(1):470. PubMed ID: 34420515 [TBL] [Abstract][Full Text] [Related]
34. Macrophage-derived GPNMB trapped by fibrotic extracellular matrix promotes pulmonary fibrosis. Wang J; Zhang X; Long M; Yuan M; Yin J; Luo W; Wang S; Cai Y; Jiang W; Chao J Commun Biol; 2023 Feb; 6(1):136. PubMed ID: 36732560 [TBL] [Abstract][Full Text] [Related]
36. Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients. Krygier A; Szmajda-Krygier D; Świechowski R; Pietrzak J; Wosiak A; Wodziński D; Balcerczak E Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551272 [TBL] [Abstract][Full Text] [Related]
37. Post-treatment with a heat shock protein 90 inhibitor prevents chronic lung injury and pulmonary fibrosis, following acute exposure of mice to HCl. Marinova M; Solopov P; Dimitropoulou C; Colunga Biancatelli RML; Catravas JD Exp Lung Res; 2020; 46(6):203-216. PubMed ID: 32400213 [No Abstract] [Full Text] [Related]
38. Identification of Prognostic Metabolomic Biomarkers at the Interface of Mortality and Morbidity in Pre-Existing TB Cases Infected With SARS-CoV-2. Diboun I; Cyprian FS; Anwardeen NR; Yassine HM; Elrayess MA; Rahmoon SM; Sayed SK; Schuchardt S; Khatib M; Bansal D; Farag EABA; Emara MM; Abdallah AM Front Cell Infect Microbiol; 2022; 12():929689. PubMed ID: 35937683 [TBL] [Abstract][Full Text] [Related]
39. Potential mechanisms for lung fibrosis associated with COVID-19 infection. Parimon T; Espindola M; Marchevsky A; Rampolla R; Chen P; Hogaboam CM QJM; 2023 Jul; 116(7):487-492. PubMed ID: 36018274 [TBL] [Abstract][Full Text] [Related]
40. Novel insight from the first lung transplant of a COVID-19 patient. Chen XJ; Li K; Xu L; Yu YJ; Wu B; He YL; Zhao WE; Li D; Luan CX; Hu L; Wang J; Ding JJ; Yu YF; Li JX; Tan ZM; Liu XF; Wei D; Zhang ZH; Guo XJ; Su C; Hu ZB; Guo YS; Chen JY; Chen F Eur J Clin Invest; 2021 Jan; 51(1):e13443. PubMed ID: 33131070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]